Global Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Regional Outlook and Forecast, 2023 - 2030
Published Date : 30-Jun-2023 | Pages: 126 | Formats: PDF |
COVID-19 Impact on the Bispecific Antibodies Market
Market Overview
The Global Bispecific Antibodies Market size is expected to reach $80.2 billion by 2030, rising at a market growth of 40.9% CAGR during the forecast period.
A significant factor that will increase the market's growth rate is the increase in cancer incidence. Cancer segment is expected to generate more than 68% share of the market by 2030. The prevalence of sedentary lifestyle adoption suggests that many individuals are active, which increases their chance of developing cancer. The International Agency for Research on Cancer estimates that in Mexico, Argentina, and Saudi Arabia, there were, respectively, 195499, 130 878, and 27 885 new cases of cancer in 2020. The risk of cancer is further increased by a sedentary lifestyle that involves eating fast food and packaged goods. Therefore, growth in adopting a sedentary lifestyle reflects a rise in cancer rates, prompting the creation of more effective cancer medicines. Hence, the rising prevalence of these diseases and disorders is further expediting the expansion of the market.
The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In May, 2020, Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, signed an agreement with Lava Therapeutics B.V to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer. Additionally, In June, 2020, F. Hoffmann-La Roche Ltd. joined hands with Innovent Biologics, Inc. for the treatment of cancer, metabolic, autoimmune, and other major diseases. The collaboration aims at discovering, developing, and commercialization of bispecific antibodies and multiple cell therapies.
KBV Cardinal Matrix - Market Competition Analysis
Based on the Analysis presented in the KBV Cardinal matrix; Pfizer, Inc. is the major forerunner in the Market. In January, 2022, Pfizer signed a research collaboration and license agreement with Dren Bio to concentrate on the discovery and development of therapeutic bispecific antibodies for selecting oncology targets utilizing Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform. Companies such as Johnson & Johnson, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC are some of the key innovators in the Market.
Market Growth Factors
Rising possibilities for focused and customized therapy
The growing demand for individualized and targeted medicines is anticipated to be favorable for the market. BsAbs have the ability to be created to specifically target particular cell types or chemicals, enabling a more targeted, effective therapy with fewer adverse effects. In the context of uncommon diseases, when conventional medicines may not be accessible or effective, this tailored approach is especially pertinent. Therefore, the growing demand for bispecific antibodies to be used in personalized and targeted medicines will drive the growth of the market in the coming years.
Growing research & development endeavors
Bispecific antibodies with distinct biological and pharmacological properties are the subject of intense research because they have the potential to be effective therapeutic agents. The development of more potent and accurate target medication candidates is anticipated to be facilitated by advancements and innovation in antibody and proton engineering. The possibility to produce more than 50 new medication forms has recently been made possible by the application of these cutting-edge bioengineering approaches. Investments made to create cutting-edge technology and expand the number of developing marketplaces also contribute to the market's growth. These elements will present advantageous chances for the market to expand.
Market Restraining Factors
Safety and immunogenicity concerns owing to adverse side effects
Like any therapeutic agents, bispecific antibodies need to demonstrate a favorable safety profile. Concerns regarding potential toxicities and immunogenicity (i.e., the immune system's response to the antibodies) can impact the development and acceptance of bispecific antibodies. The FDA granted Blinatumomab approval in 2014 for treating acute lymphoblastic leukaemia (ALL) that has relapsed or become resistant. There is emerging knowledge of the intrinsic and potentially fatal negative consequences of antibody-based immunotherapies and their amazing clinical success. Therefore, these elements are obstructing the growth of the market.
Indication Outlook
Based on indication, the market is characterized into cancer, inflammatory & autoimmune disorder, and others. The inflammatory and autoimmune disorder segment procured a considerable growth rate in the market in 2022. Rheumatoid arthritis, Crohn's disease, psoriasis, and multiple sclerosis are just a few of the illnesses that fall under the category of autoimmune and inflammatory disorders. Chronic inflammation, tissue damage, and organ malfunction can result from these conditions, which can majorly impact a patient's quality of life. Many individuals with these illnesses don't respond well to or are intolerant of current treatments, leading to serious unmet medical requirements.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 5.4 Billion |
| Market size forecast in 2030 | USD 80.2 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 40.9% from 2023 to 2030 |
| Number of Pages | 126 |
| Number of Table | 173 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling |
| Segments covered | Indication, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the market in 2022. Some of the primary variables influencing the regional market's growth are the existence of multiple market participants and the various developments undertaken by them. This has resulted in an increase in R&D spending, technological developments, and higher demand. In order to take advantage of complementary skills and technology to generate bispecific antibodies, businesses are also actively collaborating and forming partnerships. Such collaborations have sped up research and development efforts, contributing to the market's growth.
Free Valuable Insights: Global Bispecific Antibodies Market size to reach USD 80.2 Billion by 2030
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amgen, Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., Akeso, Inc., Johnson & Johnson (Janssen Global Services, LLC), Taisho Pharmaceuticals Holding Co., Ltd., Immunocore Holdings plc, GlaxoSmithKline PLC (GSK), Novartis AG, and Allergan PLC (AbbVie, Inc.).
Strategies deployed in the Market
» Partnerships, Collaborations and Agreements:
- Dec-2022: Akeso Inc. teamed up with Summit Therapeutics Inc., a clinical-stage drug discovery and development company. Through this collaboration, the company aimed at developing and marketing its ivonescimab in the United States, Canada, Europe, and Japan.
- Jun-2022: Immunocore Holdings Plc teamed up with Sanofi, a pharmaceutical and healthcare company. This hypothesis would be tested in Sanofi's clinical trial in patients with metastatic cutaneous melanoma (mCM), a population with significant unmet medical needs.
- Jan-2022: Amgen teamed up with Amgen Generate Biomedicines, a therapeutics company. Under this collaboration, the companies aimed to develop and manufacture protein therapeutics to address 5 clinical ailments.
- Jan-2022: Pfizer signed a research collaboration and license agreement with Dren Bio, a biopharmaceutical company, a developer of therapeutic antibodies for the treatment of cancer. This agreement aimed to concentrate on the discovery and development of therapeutic bispecific antibodies for selecting oncology targets utilizing Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform.
- Oct-2021: Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, entered into collaboration with Xencor, Inc., a clinical-stage biopharmaceutical company. The collaboration aimed for the development and commercialization of plamotamab and novel XmAb® B-cell addressing bispecific antibodies, designed to conditionally activate T cells through the CD28 co-stimulatory receptor.
»Acquisitions and Merger::
- Jul-2021: Amgen took over Teneobio, a clinical-stage biotechnology company. With this acquisition, the company aimed to leverage Teneobio's antibody platform to complement its prevailing capabilities. Moreover, the company also aimed to gain a diverse range of building blocks that can be created into new multispecific therapeutics.
» Trials and Approvals:
- Jun-2023: F. Hoffmann-La Roche Ltd. received FDA approval for its glofitamab, a new drug to be used in the treatment of diffuse large B-cell lymphoma (DLBCL) and large B-cell lymphoma (LBCL) arising from follicular lymphoma. The company announced that the drug would be marketed under the brand name Columvi.
Scope of the Study
Market Segments Covered in the Report:
By Indication
- Cancer
- Inflammatory & Autoimmune Disorder
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Amgen, Inc.
- F.Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Akeso, Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Taisho Pharmaceuticals Holding Co., Ltd.
- Immunocore Holdings plc
- GlaxoSmithKline PLC (GSK)
- Novartis AG
- Allergan PLC (AbbVie, Inc.)
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Bispecific Antibodies Market, by Indication
1.4.2 Global Bispecific Antibodies Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Trials and Approvals
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
Chapter 4. Global Bispecific Antibodies Market by Indication
4.1 Global Cancer Market by Region
4.2 Global Inflammatory & Autoimmune Disorder Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Bispecific Antibodies Market by Region
5.1 North America Bispecific Antibodies Market
5.1.1 North America Bispecific Antibodies Market by Indication
5.1.1.1 North America Cancer Market by Country
5.1.1.2 North America Inflammatory & Autoimmune Disorder Market by Country
5.1.1.3 North America Others Market by Country
5.1.2 North America Bispecific Antibodies Market by Country
5.1.2.1 US Bispecific Antibodies Market
5.1.2.1.1 US Bispecific Antibodies Market by Indication
5.1.2.2 Canada Bispecific Antibodies Market
5.1.2.2.1 Canada Bispecific Antibodies Market by Indication
5.1.2.3 Mexico Bispecific Antibodies Market
5.1.2.3.1 Mexico Bispecific Antibodies Market by Indication
5.1.2.4 Rest of North America Bispecific Antibodies Market
5.1.2.4.1 Rest of North America Bispecific Antibodies Market by Indication
5.2 Europe Bispecific Antibodies Market
5.2.1 Europe Bispecific Antibodies Market by Indication
5.2.1.1 Europe Cancer Market by Country
5.2.1.2 Europe Inflammatory & Autoimmune Disorder Market by Country
5.2.1.3 Europe Others Market by Country
5.2.2 Europe Bispecific Antibodies Market by Country
5.2.2.1 Germany Bispecific Antibodies Market
5.2.2.1.1 Germany Bispecific Antibodies Market by Indication
5.2.2.2 UK Bispecific Antibodies Market
5.2.2.2.1 UK Bispecific Antibodies Market by Indication
5.2.2.3 France Bispecific Antibodies Market
5.2.2.3.1 France Bispecific Antibodies Market by Indication
5.2.2.4 Russia Bispecific Antibodies Market
5.2.2.4.1 Russia Bispecific Antibodies Market by Indication
5.2.2.5 Spain Bispecific Antibodies Market
5.2.2.5.1 Spain Bispecific Antibodies Market by Indication
5.2.2.6 Italy Bispecific Antibodies Market
5.2.2.6.1 Italy Bispecific Antibodies Market by Indication
5.2.2.7 Rest of Europe Bispecific Antibodies Market
5.2.2.7.1 Rest of Europe Bispecific Antibodies Market by Indication
5.3 Asia Pacific Bispecific Antibodies Market
5.3.1 Asia Pacific Bispecific Antibodies Market by Indication
5.3.1.1 Asia Pacific Cancer Market by Country
5.3.1.2 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country
5.3.1.3 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Bispecific Antibodies Market by Country
5.3.2.1 China Bispecific Antibodies Market
5.3.2.1.1 China Bispecific Antibodies Market by Indication
5.3.2.2 Japan Bispecific Antibodies Market
5.3.2.2.1 Japan Bispecific Antibodies Market by Indication
5.3.2.3 India Bispecific Antibodies Market
5.3.2.3.1 India Bispecific Antibodies Market by Indication
5.3.2.4 South Korea Bispecific Antibodies Market
5.3.2.4.1 South Korea Bispecific Antibodies Market by Indication
5.3.2.5 Singapore Bispecific Antibodies Market
5.3.2.5.1 Singapore Bispecific Antibodies Market by Indication
5.3.2.6 Malaysia Bispecific Antibodies Market
5.3.2.6.1 Malaysia Bispecific Antibodies Market by Indication
5.3.2.7 Rest of Asia Pacific Bispecific Antibodies Market
5.3.2.7.1 Rest of Asia Pacific Bispecific Antibodies Market by Indication
5.4 LAMEA Bispecific Antibodies Market
5.4.1 LAMEA Bispecific Antibodies Market by Indication
5.4.1.1 LAMEA Cancer Market by Country
5.4.1.2 LAMEA Inflammatory & Autoimmune Disorder Market by Country
5.4.1.3 LAMEA Others Market by Country
5.4.2 LAMEA Bispecific Antibodies Market by Country
5.4.2.1 Brazil Bispecific Antibodies Market
5.4.2.1.1 Brazil Bispecific Antibodies Market by Indication
5.4.2.2 Argentina Bispecific Antibodies Market
5.4.2.2.1 Argentina Bispecific Antibodies Market by Indication
5.4.2.3 UAE Bispecific Antibodies Market
5.4.2.3.1 UAE Bispecific Antibodies Market by Indication
5.4.2.4 Saudi Arabia Bispecific Antibodies Market
5.4.2.4.1 Saudi Arabia Bispecific Antibodies Market by Indication
5.4.2.5 South Africa Bispecific Antibodies Market
5.4.2.5.1 South Africa Bispecific Antibodies Market by Indication
5.4.2.6 Nigeria Bispecific Antibodies Market
5.4.2.6.1 Nigeria Bispecific Antibodies Market by Indication
5.4.2.7 Rest of LAMEA Bispecific Antibodies Market
5.4.2.7.1 Rest of LAMEA Bispecific Antibodies Market by Indication
Chapter 6. Company Profiles
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Trials and Approvals:
6.3 Pfizer, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 Akeso, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Johnson & Johnson (Janssen Global Services, LLC)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental &Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Acquisition and Mergers:
6.6 Taisho Pharmaceuticals Holding Co., Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Immunocore Holdings plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 Recent strategies and developments:
6.7.4.1 Partnerships, Collaborations, and Agreements:
6.8 GlaxoSmithKline PLC (GSK)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Novartis AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Allergan PLC (AbbVie, Inc.)
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Bispecific Antibodies Market, by Indication
1.4.2 Global Bispecific Antibodies Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Trials and Approvals
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
Chapter 4. Global Bispecific Antibodies Market by Indication
4.1 Global Cancer Market by Region
4.2 Global Inflammatory & Autoimmune Disorder Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Bispecific Antibodies Market by Region
5.1 North America Bispecific Antibodies Market
5.1.1 North America Bispecific Antibodies Market by Indication
5.1.1.1 North America Cancer Market by Country
5.1.1.2 North America Inflammatory & Autoimmune Disorder Market by Country
5.1.1.3 North America Others Market by Country
5.1.2 North America Bispecific Antibodies Market by Country
5.1.2.1 US Bispecific Antibodies Market
5.1.2.1.1 US Bispecific Antibodies Market by Indication
5.1.2.2 Canada Bispecific Antibodies Market
5.1.2.2.1 Canada Bispecific Antibodies Market by Indication
5.1.2.3 Mexico Bispecific Antibodies Market
5.1.2.3.1 Mexico Bispecific Antibodies Market by Indication
5.1.2.4 Rest of North America Bispecific Antibodies Market
5.1.2.4.1 Rest of North America Bispecific Antibodies Market by Indication
5.2 Europe Bispecific Antibodies Market
5.2.1 Europe Bispecific Antibodies Market by Indication
5.2.1.1 Europe Cancer Market by Country
5.2.1.2 Europe Inflammatory & Autoimmune Disorder Market by Country
5.2.1.3 Europe Others Market by Country
5.2.2 Europe Bispecific Antibodies Market by Country
5.2.2.1 Germany Bispecific Antibodies Market
5.2.2.1.1 Germany Bispecific Antibodies Market by Indication
5.2.2.2 UK Bispecific Antibodies Market
5.2.2.2.1 UK Bispecific Antibodies Market by Indication
5.2.2.3 France Bispecific Antibodies Market
5.2.2.3.1 France Bispecific Antibodies Market by Indication
5.2.2.4 Russia Bispecific Antibodies Market
5.2.2.4.1 Russia Bispecific Antibodies Market by Indication
5.2.2.5 Spain Bispecific Antibodies Market
5.2.2.5.1 Spain Bispecific Antibodies Market by Indication
5.2.2.6 Italy Bispecific Antibodies Market
5.2.2.6.1 Italy Bispecific Antibodies Market by Indication
5.2.2.7 Rest of Europe Bispecific Antibodies Market
5.2.2.7.1 Rest of Europe Bispecific Antibodies Market by Indication
5.3 Asia Pacific Bispecific Antibodies Market
5.3.1 Asia Pacific Bispecific Antibodies Market by Indication
5.3.1.1 Asia Pacific Cancer Market by Country
5.3.1.2 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country
5.3.1.3 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Bispecific Antibodies Market by Country
5.3.2.1 China Bispecific Antibodies Market
5.3.2.1.1 China Bispecific Antibodies Market by Indication
5.3.2.2 Japan Bispecific Antibodies Market
5.3.2.2.1 Japan Bispecific Antibodies Market by Indication
5.3.2.3 India Bispecific Antibodies Market
5.3.2.3.1 India Bispecific Antibodies Market by Indication
5.3.2.4 South Korea Bispecific Antibodies Market
5.3.2.4.1 South Korea Bispecific Antibodies Market by Indication
5.3.2.5 Singapore Bispecific Antibodies Market
5.3.2.5.1 Singapore Bispecific Antibodies Market by Indication
5.3.2.6 Malaysia Bispecific Antibodies Market
5.3.2.6.1 Malaysia Bispecific Antibodies Market by Indication
5.3.2.7 Rest of Asia Pacific Bispecific Antibodies Market
5.3.2.7.1 Rest of Asia Pacific Bispecific Antibodies Market by Indication
5.4 LAMEA Bispecific Antibodies Market
5.4.1 LAMEA Bispecific Antibodies Market by Indication
5.4.1.1 LAMEA Cancer Market by Country
5.4.1.2 LAMEA Inflammatory & Autoimmune Disorder Market by Country
5.4.1.3 LAMEA Others Market by Country
5.4.2 LAMEA Bispecific Antibodies Market by Country
5.4.2.1 Brazil Bispecific Antibodies Market
5.4.2.1.1 Brazil Bispecific Antibodies Market by Indication
5.4.2.2 Argentina Bispecific Antibodies Market
5.4.2.2.1 Argentina Bispecific Antibodies Market by Indication
5.4.2.3 UAE Bispecific Antibodies Market
5.4.2.3.1 UAE Bispecific Antibodies Market by Indication
5.4.2.4 Saudi Arabia Bispecific Antibodies Market
5.4.2.4.1 Saudi Arabia Bispecific Antibodies Market by Indication
5.4.2.5 South Africa Bispecific Antibodies Market
5.4.2.5.1 South Africa Bispecific Antibodies Market by Indication
5.4.2.6 Nigeria Bispecific Antibodies Market
5.4.2.6.1 Nigeria Bispecific Antibodies Market by Indication
5.4.2.7 Rest of LAMEA Bispecific Antibodies Market
5.4.2.7.1 Rest of LAMEA Bispecific Antibodies Market by Indication
Chapter 6. Company Profiles
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Trials and Approvals:
6.3 Pfizer, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 Akeso, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Johnson & Johnson (Janssen Global Services, LLC)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental &Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Acquisition and Mergers:
6.6 Taisho Pharmaceuticals Holding Co., Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Immunocore Holdings plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 Recent strategies and developments:
6.7.4.1 Partnerships, Collaborations, and Agreements:
6.8 GlaxoSmithKline PLC (GSK)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Novartis AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Allergan PLC (AbbVie, Inc.)
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
List of Tables
TABLE 1 Global Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 2 Global Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bispecific Antibodies Market
TABLE 4 Trials and Approvals – Bispecific Antibodies Market
TABLE 5 Acquisition and Mergers– Bispecific Antibodies Market
TABLE 6 Global Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 7 Global Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 8 Global Cancer Market by Region, 2019 - 2022, USD Million
TABLE 9 Global Cancer Market by Region, 2023 - 2030, USD Million
TABLE 10 Global Inflammatory & Autoimmune Disorder Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Inflammatory & Autoimmune Disorder Market by Region, 2023 - 2030, USD Million
TABLE 12 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 13 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 14 Global Bispecific Antibodies Market by Region, 2019 - 2022, USD Million
TABLE 15 Global Bispecific Antibodies Market by Region, 2023 - 2030, USD Million
TABLE 16 North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 17 North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 18 North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 19 North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 20 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 22 North America Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 24 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 26 North America Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 28 US Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 29 US Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 30 US Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 31 US Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 32 Canada Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 33 Canada Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 34 Canada Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 35 Canada Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 36 Mexico Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 37 Mexico Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 38 Mexico Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 39 Mexico Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 40 Rest of North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 41 Rest of North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 42 Rest of North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 43 Rest of North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 44 Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 45 Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 46 Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 47 Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 48 Europe Cancer Market by Country, 2019 - 2022, USD Million
TABLE 49 Europe Cancer Market by Country, 2023 - 2030, USD Million
TABLE 50 Europe Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 51 Europe Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 52 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 53 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 54 Europe Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 55 Europe Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 56 Germany Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 57 Germany Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 58 Germany Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 59 Germany Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 60 UK Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 61 UK Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 62 UK Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 63 UK Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 64 France Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 65 France Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 66 France Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 67 France Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 68 Russia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 69 Russia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 70 Russia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 71 Russia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 72 Spain Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 73 Spain Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 74 Spain Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 75 Spain Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 76 Italy Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 77 Italy Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 78 Italy Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 79 Italy Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 80 Rest of Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 81 Rest of Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 82 Rest of Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 83 Rest of Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 84 Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 85 Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 86 Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 87 Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 88 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
TABLE 89 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
TABLE 90 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 91 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 92 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 93 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 94 Asia Pacific Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 95 Asia Pacific Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 96 China Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 97 China Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 98 China Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 99 China Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 100 Japan Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 101 Japan Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 102 Japan Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 103 Japan Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 104 India Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 105 India Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 106 India Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 107 India Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 108 South Korea Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 109 South Korea Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 110 South Korea Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 111 South Korea Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 112 Singapore Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 113 Singapore Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 114 Singapore Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 115 Singapore Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 116 Malaysia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 117 Malaysia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 118 Malaysia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 119 Malaysia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 120 Rest of Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 121 Rest of Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 122 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 123 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 124 LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 125 LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 126 LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 127 LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 128 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
TABLE 129 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
TABLE 130 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 131 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 132 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 133 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 134 LAMEA Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 135 LAMEA Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 136 Brazil Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 137 Brazil Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 138 Brazil Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 139 Brazil Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 140 Argentina Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 141 Argentina Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 142 Argentina Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 143 Argentina Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 144 UAE Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 145 UAE Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 146 UAE Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 147 UAE Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 148 Saudi Arabia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 149 Saudi Arabia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 150 Saudi Arabia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 151 Saudi Arabia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 152 South Africa Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 153 South Africa Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 154 South Africa Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 155 South Africa Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 156 Nigeria Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 157 Nigeria Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 158 Nigeria Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 159 Nigeria Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 160 Rest of LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 161 Rest of LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 162 Rest of LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 163 Rest of LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 164 Key Information – Amgen, Inc.
TABLE 165 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 166 Key Information – Pfizer, Inc.
TABLE 167 Key Information – Akeso, Inc.
TABLE 168 Key information –Johnson & Johnson
TABLE 169 key Information – Taisho Pharmaceuticals Holding Co., Ltd.
TABLE 170 Key Information – Immunocore Holdings plc
TABLE 171 Key Information – GlaxoSmithKline PLC
TABLE 172 Key Information – Novartis AG
TABLE 173 Key Information – Allergan PLC
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
FIG 5 Global Bispecific Antibodies Market share by Indication, 2022
FIG 6 Global Bispecific Antibodies Market share by Indication, 2030
FIG 7 Global Bispecific Antibodies Market by Indication, 2019 - 2030, USD Million
FIG 8 Global Bispecific Antibodies Market share by Region, 2022
FIG 9 Global Bispecific Antibodies Market share by Region, 2030
FIG 10 Global Bispecific Antibodies Market by Region, 2019 - 2030, USD Million
FIG 11 Recent strategies and developments: Johnson & Johnson
TABLE 2 Global Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bispecific Antibodies Market
TABLE 4 Trials and Approvals – Bispecific Antibodies Market
TABLE 5 Acquisition and Mergers– Bispecific Antibodies Market
TABLE 6 Global Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 7 Global Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 8 Global Cancer Market by Region, 2019 - 2022, USD Million
TABLE 9 Global Cancer Market by Region, 2023 - 2030, USD Million
TABLE 10 Global Inflammatory & Autoimmune Disorder Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Inflammatory & Autoimmune Disorder Market by Region, 2023 - 2030, USD Million
TABLE 12 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 13 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 14 Global Bispecific Antibodies Market by Region, 2019 - 2022, USD Million
TABLE 15 Global Bispecific Antibodies Market by Region, 2023 - 2030, USD Million
TABLE 16 North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 17 North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 18 North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 19 North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 20 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 22 North America Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 24 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 26 North America Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 28 US Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 29 US Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 30 US Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 31 US Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 32 Canada Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 33 Canada Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 34 Canada Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 35 Canada Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 36 Mexico Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 37 Mexico Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 38 Mexico Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 39 Mexico Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 40 Rest of North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 41 Rest of North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 42 Rest of North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 43 Rest of North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 44 Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 45 Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 46 Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 47 Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 48 Europe Cancer Market by Country, 2019 - 2022, USD Million
TABLE 49 Europe Cancer Market by Country, 2023 - 2030, USD Million
TABLE 50 Europe Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 51 Europe Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 52 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 53 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 54 Europe Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 55 Europe Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 56 Germany Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 57 Germany Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 58 Germany Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 59 Germany Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 60 UK Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 61 UK Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 62 UK Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 63 UK Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 64 France Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 65 France Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 66 France Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 67 France Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 68 Russia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 69 Russia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 70 Russia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 71 Russia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 72 Spain Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 73 Spain Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 74 Spain Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 75 Spain Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 76 Italy Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 77 Italy Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 78 Italy Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 79 Italy Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 80 Rest of Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 81 Rest of Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 82 Rest of Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 83 Rest of Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 84 Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 85 Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 86 Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 87 Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 88 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
TABLE 89 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
TABLE 90 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 91 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 92 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 93 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 94 Asia Pacific Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 95 Asia Pacific Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 96 China Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 97 China Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 98 China Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 99 China Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 100 Japan Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 101 Japan Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 102 Japan Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 103 Japan Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 104 India Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 105 India Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 106 India Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 107 India Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 108 South Korea Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 109 South Korea Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 110 South Korea Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 111 South Korea Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 112 Singapore Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 113 Singapore Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 114 Singapore Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 115 Singapore Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 116 Malaysia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 117 Malaysia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 118 Malaysia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 119 Malaysia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 120 Rest of Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 121 Rest of Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 122 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 123 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 124 LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 125 LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 126 LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 127 LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 128 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
TABLE 129 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
TABLE 130 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 131 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 132 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 133 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 134 LAMEA Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 135 LAMEA Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 136 Brazil Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 137 Brazil Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 138 Brazil Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 139 Brazil Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 140 Argentina Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 141 Argentina Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 142 Argentina Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 143 Argentina Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 144 UAE Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 145 UAE Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 146 UAE Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 147 UAE Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 148 Saudi Arabia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 149 Saudi Arabia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 150 Saudi Arabia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 151 Saudi Arabia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 152 South Africa Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 153 South Africa Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 154 South Africa Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 155 South Africa Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 156 Nigeria Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 157 Nigeria Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 158 Nigeria Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 159 Nigeria Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 160 Rest of LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 161 Rest of LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 162 Rest of LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 163 Rest of LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 164 Key Information – Amgen, Inc.
TABLE 165 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 166 Key Information – Pfizer, Inc.
TABLE 167 Key Information – Akeso, Inc.
TABLE 168 Key information –Johnson & Johnson
TABLE 169 key Information – Taisho Pharmaceuticals Holding Co., Ltd.
TABLE 170 Key Information – Immunocore Holdings plc
TABLE 171 Key Information – GlaxoSmithKline PLC
TABLE 172 Key Information – Novartis AG
TABLE 173 Key Information – Allergan PLC
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
FIG 5 Global Bispecific Antibodies Market share by Indication, 2022
FIG 6 Global Bispecific Antibodies Market share by Indication, 2030
FIG 7 Global Bispecific Antibodies Market by Indication, 2019 - 2030, USD Million
FIG 8 Global Bispecific Antibodies Market share by Region, 2022
FIG 9 Global Bispecific Antibodies Market share by Region, 2030
FIG 10 Global Bispecific Antibodies Market by Region, 2019 - 2030, USD Million
FIG 11 Recent strategies and developments: Johnson & Johnson